Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :18617530
Publication Date : //

Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.

The EPM2A gene, encoding the dual-phosphatase laforin, is mutated in a fatal form of progressive myoclonus epilepsy known as Lafora disease (LD). The EPM2A gene, by differential splicing of its transcripts, is known to encode two laforin isoforms having distinct carboxyl termini; a major isoform localized in the cytoplasm (laf331), and a minor isoform that is targeted to the nucleus as well (laf317). We show here that the two laforin isoforms interact with each other and form homo and heterodimers. The homodimer of laf331 display robust phosphatase activity, whereas the laf317 homodimer and the laf331-laf317 heterodimer lack phosphatase activity. Laf331 binds to glycogen only as a monomeric form. Laf317, on the other hand, was unable to bind to glycogen as a homodimer or as a heterodimer. Similar to laf331, laf317 interacts with and functions as a substrate for the malin ubiquitin ligase--a product of another gene defective in LD. Malin, however, shows higher affinity towards laf331 when compared with laf317. We have also tested the effect of LD-associated mutations, whose effects are restricted to the laf331 isoform, on laf331-laf317 interaction. Two such mutations are known and both abolish the interactions between laf317 and laf331 and their heterodimerization, but not the homodimerization property of laf331. Thus, laf317 could function as a dominant-negative regulator of laf331, and laf331-specific mutations might affect laf317 functions as well. Thus, our findings reveal a novel mechanism for the EPM2A gene function, regulated by alternative splicing, in normal as well as disease conditions.

Authors : Dubey Deepti , Ganesh Subramaniam ,

Related products :

Catalog number Product name Quantity
EPN1 EPM2A Gene epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
20-372-60229 epilepsy. progressive myoclonus type 2A. Lafora disease (laforin) (EPM2A). transcript variant 1 - Mouse monoclonal anti-human EPM2A antibody; EC; EC; Lafora PTPase; LAFPTPase Monoclo 0.1 mg
60229 IgG,epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A), transcript variant 1 0.1 mg
GWB-835A73 epilepsy progressive myoclonus type 2A Lafora disease (laforin) (EPM2A) transcript variant 1, Antibody
CSB-EL007738RA Rat epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL007738DO Dog epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Dog, Sample Type serum, plasma 96T
CSB-EL007738MO Mouse epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL007738HU Human epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) ELISA kit, Species Human, Sample Type serum, plasma 96T
EIAAB13122 Epm2a,Lafora PTPase,Laforin,LAFPTPase,Rat,Rattus norvegicus
EIAAB13124 Epm2a,Lafora PTPase,Laforin,LAFPTPase,Mouse,Mus musculus
EIAAB13123 EPM2A,Homo sapiens,Human,Lafora PTPase,Laforin,LAFPTPase
28-738 ZNF265 is a protein that has been shown to bind to the spliceosomal components U1-70K and U2AF35 and to direct alternative splicing. Analysis of the structure reveals substantial similarity to known R 0.1 mg
EIAAB13121 Canis familiaris,Canis lupus familiaris,Dog,EPM2A,Lafora PTPase,Laforin,LAFPTPase
CLNK CLN8 Gene ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
EPN2 EPM2AIP1 Gene EPM2A (laforin) interacting protein 1
EPM2A_MOUSE ELISA Kit FOR Laforin; organism: Mouse; gene name: Epm2a 96T
29-368 SFRS6 is involved in mRNA splicing and may play a role in the determination of alternative splicing. It belongs to the splicing factor SR family and has been shown to bind with and modulate another me 0.05 mg
EIAAB39962 Alternative-splicing factor 1,ASF,ASF-1,Homo sapiens,Human,OK_SW-cl.3,pre-mRNA-splicing factor SF2, P33 subunit,Serine_arginine-rich splicing factor 1,SF2,SF2P33,SFRS1,Splicing factor, arginine_serine
CSB-EL007738RA Rat Laforin(EPM2A) ELISA kit 96T
CSB-EL007738DO Dog Laforin(EPM2A) ELISA kit 96T
ant-427 Mouse Anti Human Laforin EPM2A 20
CSB-EL007738MO Mouse Laforin(EPM2A) ELISA kit 96T
CSB-EL007738HU Human Laforin(EPM2A) ELISA kit 96T
ant-427 Mouse Anti Human Laforin EPM2A 5
CSB-EL007738RA Rat Laforin(EPM2A) ELISA kit SpeciesRat 96T


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur

Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017


france@gentaur.com | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur